Biotech · Private company

TopAlliance Biosciences

Track this companyFree. Adds TopAlliance Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials

Pipeline4

Clinical trials2

  • Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesPHASE1 · UNKNOWN · started Oct 30, 2019ClinicalTrials.gov NCT04137900 · fetched Nov 12, 2026
  • Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesPHASE1 · COMPLETED · started Feb 21, 2018ClinicalTrials.gov NCT03474640 · fetched Nov 12, 2026